S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Sanntidsoppdatering for Apexigen, Inc. [APGN]

Børs: NASDAQ Capital Market Sektor: Healthcare Industri: Biotechnology
Sist oppdatert22 aug 2023 @ 21:59

8.48% $ 0.385

Live Chart Being Loaded With Signals

Commentary (22 aug 2023 @ 21:59):

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells...

Stats
Dagens volum 94 426.00
Gjennomsnittsvolum 262 332
Markedsverdi 9.57M
EPS $0 ( 2023-11-21 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.225
ATR14 $0.0390 (10.13%)
Insider Trading
Date Person Action Amount type
2023-08-23 Zabrowksi Dan Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 146 383 Common Stock
2023-08-23 Wertheimer Samuel P Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 12 383 Warrants (right to buy)
2023-08-23 Wertheimer Samuel P Sell 1 845 Warrants (right to buy)
INSIDER POWER
-60.29
Last 97 transactions
Buy: 2 466 920 | Sell: 6 182 886

Volum Korrelasjon

Lang: 0.28 (neutral)
Kort: 0.00 (neutral)
Signal:(44.278) Neutral

Apexigen, Inc. Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Apexigen, Inc. Korrelasjon - Valuta/Råvare

The country flag -0.66
( moderate negative )
The country flag -0.33
( neutral )
The country flag 0.00
( neutral )
The country flag -0.67
( moderate negative )
The country flag 0.57
( weak )

Apexigen, Inc. Økonomi

Annual 2022
Omsetning: $0
Bruttogevinst: $0 (0.00 %)
EPS: $-1.590
FY 2022
Omsetning: $0
Bruttogevinst: $0 (0.00 %)
EPS: $-1.590
FY 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-0.931
FY 2020
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-3.36

Financial Reports:

No articles found.

Apexigen, Inc.

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.